Posted by AGORACOM-JC
at 8:37 AM on Wednesday, May 8th, 2019
Announced that its wholly owned subsidiary, hempSMART, Ltd., is taking steps to list on the Vienna Stock Exchange (H Smart SARL),
Intends to raise sufficient capital to expedite the rollout of its hempSMART™ product line in Europe.
Escondido, California–(May 8, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary, hempSMART, Ltd., is taking steps to list on the Vienna Stock Exchange (H Smart SARL), with the intention of raising sufficient capital to expedite the rollout of its hempSMART™ product line in Europe.
Marijuana Company of America plans to sell a minority interest of
hempSMART, Ltd., currently engaged in developing and marketing the
hempSMART brand in Europe, for up to $10 million. The Company expects
that all of the necessary steps to trade on the Vienna exchange will be
completed by the beginning of the third quarter of 2019.
Once listed, hempSMART, Ltd. will be one of the first U.S.-based
hemp-derived cannabidiol (CBD) companies to do an initial listing on a
European exchange, as most cannabis and hemp public companies opt to
list in Europe as a secondary listing. This is a result of the Company’s
commitment to prioritizing its marketing efforts in the burgeoning
European cannabis, hemp and CBD markets, with future plans to expand
further.
“We are very excited to do an IPO of hempSMART, Ltd. on such a
reputable European exchange,” said Don Steinberg, CEO of Marijuana
Company of America. “This is a huge leap forward to obtain the necessary
capital to bolster our European launch and become a top hemp brand in
Europe. Europe’s cannabis and hemp markets are undergoing a critical
phase in their growth and this is the optimum time to establish our
brand as a leader. To date, we have exceeded expectations at our London
event in March. In order to capitalize on this positive market momentum,
we have planned two additional events in England, with two more
following in Liverpool and Birmingham.”
hempSMART, Ltd. is expected to enter Portugal later this month, with
future plans to extend further in France, Germany and Austria.
hempSMART, Ltd. markets and sells the Company’s hemp and hemp-based
personal wellness products, including the U.S.-patented hempSMART
Brain™, an effective wellness product formulated with proprietary
composition of natural ingredients and CBD to enhance brain function.
Jesus Quintero, CFO of MCOA, stated, “This offering on the Vienna
exchange will help to strengthen the worldwide valuation for our
hempSMART brand. We are highly optimistic about the prospects of this
offering and the financial success of hempSMART.”
Ian Harvey, COO of hempSMART, Ltd., commented, “The U.S. patent
issuance is indicative of the advances the Company achieved, and is a
testament to the Company’s continued commitment to produce unique
products of the highest quality, which distinguishes hempSMART as a
leader of hemp-based CBD products.”
About Marijuana Company of America, Inc. MCOA is a
corporation that participates in: (1) product research and development
of legal hemp-based consumer products under the brand name “hempSMART™,”
which targets general health and well-being; (2) an affiliate marketing
program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business
entities engaged in the growth and sale of cannabis in those states and
jurisdictions where cannabis has been legalized and properly regulated
for medicinal and recreational use; and (4) the expansion of its
business into ancillary areas of the legalized cannabis and hemp
industry, as the legalized markets and opportunities in this segment
mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products containing
CBD derived from industrial hemp are not marketed or sold based upon
claims that their use is safe and effective treatment for any medical
condition as drugs or dietary supplements subject to the FDA’s
jurisdiction.
Forward-Looking Statements This news
release contains “forward-looking statements” that are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities and words such as “anticipate,”
“seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan” or
similar phrases may be deemed “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition, and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time to time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
Posted by AGORACOM-JC
at 9:30 PM on Tuesday, May 7th, 2019
SPONSOR: Enthusiast Gaming Holdings Inc.
(TSX-V: EGLX) Uniting gaming communities with 80 owned and affiliated
websites, currently reaching over 75 million monthly visitors. The
company exceeded 2018 target with $11.0 million in revenue. Learn More
Recent figures documented by Newzoo have suggested that revenues from esports will hit an astonishing $1.1 billion this year.
This is thanks to a phenomenal growth rate of 26.7% since 2018, and it’s clear that it is the involvement of big business that is helping esports become a world beater.
Everybody knows that esports is one of the fastest growing entertainment trends in the world. What began as a fairly nerdy activity in Korea at the turn of the century has grown to become a world-beater that is even starting to eclipse traditional sports. If there was any doubt about the success of esports, then you just have to take a look at the fact that competitive gaming is set to become a billion dollar industry in 2019.
Recent figures documented by Newzoo have suggested that revenues from
esports will hit an astonishing $1.1 billion this year. This is thanks
to a phenomenal growth rate of 26.7% since 2018, and it’s clear that it
is the involvement of big business that is helping esports become a
world beater.
Recently we have seen many multinational brands paying huge amounts
of money to advertise their products at esports tournaments and even
sponsor competitive gaming teams outright. From the likes of McDonalds
sponsoring the massive ESL esports tournaments in Germany, to Red Bull
partnering up with some of the most successful competitive gaming teams,
it seems that just about everybody is jumping on the esports bandwagon.
What’s truly remarkable is the fact that even traditional
broadcasters seem to be taking esports seriously. When the likes of ESPN
start covering gaming tournaments, it shows that something significant
is happening with many people’s perceptions of video games.
Just a few years ago, the idea of millions of people tuning in to
watch other people play games would have seemed laughable. But the fact
that over 200 million people watched last year’s League of Legends
Worlds final shows that esports is a big spectator event, plus there are
now even esports betting resources like www.esports.net that allow
people a safe and easy way to bet on the outcome of the action.
Even many of the world’s most famous sporting organisations are
seeking to get involved with esports as a way of extending their brand
appeal. From iconic soccer clubs like Paris Saint Germain and Manchester
City, to legendary American football sides such as New England
Patriots, it seems that there’s something of a goldrush to invest in the
best new esports teams and players. What makes things all the more
interesting is the way that new titles keep being added to the esports
realm. Alongside classic esports like League of Legends, Counter Strike
Global Offensive and Dota 2, recently we have seem games like Overwatch
and Playerunknown’s Battlegrounds becoming real sensations in
competitive gaming. And with new titles like Fortnite and Apex Legends
joining the fray, it seems as though there is no slowing down in the
sheer range and scope of gaming options.
For a long time it looked like the fractious and chaotic world of
esports would be impenetrable for mainstream viewing audiences. But with
Blizzard Entertainment helping to set up the Overwatch League with a
fixed set of teams and even a guaranteed player salary, it has
standardised the gaming action to make it much easier for fans to
follow.
Obviously, there is still plenty of antisocial behaviour from some
young gamers to deal with, but we are also seeing growing moves from
esports governing bodies to effectively reprimand some of the more toxic
attitudes that have made gaming off-putting for outsiders. As a result,
we are starting to see some esports being included as legitimate medal
sports in traditional sporting events such as the SEA Games later this
year. All of which shows that esports is set for a massive year in 2019.
Posted by AGORACOM-JC
at 8:30 AM on Tuesday, May 7th, 2019
Recent Company highlights include:
Global expansion with the debut of its hempSMART™ products in the UK
Established joint venture in California to operate a California cannabis delivery service named Viva Buds™
Details of the joint venture partnership with Global Hemp Group, completed a successful first harvest late in 2018 and is now in position to monetize its hemp biomass
Strategic partnership with MassRoots (OTCQB: MSRT) to promote its hempSMART CBD product line
Escondido, California–(May 7, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, today announces that on May 1, 2019, the Company mailed a letter to its shareholders to update them on recent developments and new business opportunities. In the letter, the Company provided a discussion on its two current acquisitions underway a review of its recent financial and operating performance and details of its new Viva Buds™ brand that will serve as a manufacturing, distribution and retail delivery service for cannabis products in the state of California.
Recent Company highlights include:
Marijuana Company of America’s global expansion with the debut of its hempSMART™ products in the UK
The Company’s established joint venture in California to operate a California cannabis delivery service named Viva Buds™
Details of the joint venture partnership with Global Hemp Group,
which completed a successful first harvest late in 2018 and is now in
position to monetize its hemp biomass
A strategic partnership with MassRoots (OTCQB: MSRT) to promote its hempSMART CBD product line
“Our shareholder letter addresses our hemp research and growth
business expansion, and the two joint ventures we started with Global
Hemp Group Inc. last year, which includes a working hemp farm in Oregon
that just completed its successful first harvest in late 2018,” said Mr.
Don Steinberg, Chairman and CEO of Marijuana Company of America. “We
are confident to now be strategically positioned to drive more revenue
and expand exponentially into new markets with our products and business
growth methods.”
About Marijuana Company of America Inc. MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™ which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products containing
CBD derived from industrial hemp are not marketed or sold based upon
claims that their use is safe and effective treatment for any medical
condition as drugs or dietary supplements subject to the FDA’s
jurisdiction.
Forward Looking Statements
This news release contains “forward-looking statements” that are
not purely historical and may include any statements regarding beliefs,
plans, expectations or intentions regarding the future. Such
forward-looking statements include, among other things, the development,
costs and results of new business opportunities and words such as
“anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”,
“project”, “plan”, or similar phrases may be deemed “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. Actual results could differ from those projected in
any forward-looking statements due to numerous factors. Such factors
include, among others, the inherent uncertainties associated with new
projects, the future U.S. and global economies, the impact of
competition, and the Company’s reliance on existing regulations
regarding the use and development of cannabis-based products. These
forward-looking statements are made as of the date of this news release,
and we assume no obligation to update the forward-looking statements,
or to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe that
any beliefs, plans, expectations and intentions contained in this press
release are reasonable, there can be no assurance that any such beliefs,
plans, expectations or intentions will prove to be accurate. Investors
should consult all of the information set forth herein and should also
refer to the risk factors disclosure outlined in our annual report on
Form 10-12G, our quarterly reports on Form 10-Q and other periodic
reports filed from time to time with the Securities and Exchange
Commission. For more information, please visit www.sec.gov.
Posted by AGORACOM-JC
at 12:58 PM on Monday, May 6th, 2019
“The strong support of our financing round demonstrates that shareholders and investors have faith in our ability to execute on initiatives, as we establish vertical integration connecting patient efficacy…,” stated Steven McAuley, Empower Chairman and CEO.
VANCOUVER, May 3, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company“), a growth oriented and diversified medical cannabis company, is pleased to announce the closing of the second tranche of a non-brokered private placement of unsecured convertible debentures (the “Debentures“), pursuant to which it has issued Debentures in the aggregate principal amount of $207,270, and the second tranche of a non-brokered private placement of an aggregate of 5,762,500 units of the Company (each, a Unit“) at a price of $0.10 per Unit for gross proceeds of $576,250, for combined total proceeds of $783,520 (together, the “Offerings“).
The proceeds of the Offerings are expected to be used by the Company
for the completion of strategic acquisitions and for general working
capital and corporate purposes.
“The strong support of our financing round demonstrates that
shareholders and investors have faith in our ability to execute on
initiatives, as we establish vertical integration connecting patient
efficacy in our clinics with a diverse CBD product strategy and the
backing of the science of extraction, all driven by data and analysis,”
stated Steven McAuley, Empower Chairman and CEO.
RECENT HIGHLIGHTS
Intention to Launch CBD Extraction Facility The Company intends to open a fully functioning hemp-based CBD extraction facility in greater Portland, Oregon
in Q2 2019, with the first extraction system expected to have the
capacity to produce 6,000 kilograms of extracted product per year. The
5,000 sq. ft. facility in Sandy, OR has now been secured
through a 5 year lease agreement and preparations are underway to begin
licensing and permit requirements to commence operations in 2019.
Acquisition of Sun Valley Clinics Empower has completed the acquisition of the business of Sun Valley Certification Clinics Holdings LLC (“Sun Valley“), including its interests in certain affiliates, by way of a share acquisition. Sun Valley operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona, one clinic in Las Vegas, a tele-medicine platform serving California, and a fully developed franchise business model for the domestic cannabis industry. The current Sun Valley clinic locations are as follows:
4218 W Dunlap Ave, Phoenix, AZ 12801 W Bell Rd #145, Surprise, AZ 4015 E Bell Rd #130, Phoenix, AZ 2011 E University Dr, Mesa, AZ 7074 E Speedway Blvd, Tucson, AZ 2550 S Rainbow Blvd, Las Vegas, NV
Focus on CBD Product Sales Empower has commenced
selling its proprietary line of CBD-based products called SOLLIEVO,
through its network of company-owned clinics in the United States.
Empower’s patient base and customers are expected to benefit from
access to high margin derivative products, including CBD lotion,
tinctures, spectrum oils, capsules, lozenges, patches, e-drinks, topical
lotions, gel caps, hemp extract drops and pet elixir hemp extract
drops. Patients and customers will be able to access Empower’s home
delivery and e-commerce platform.
CBD Market Demand The passing in the United States of the US$867 billion Agriculture Improvement Act (the “Farm Bill“)
has legalized hemp and hemp-based products. This has created an
opportunity for the production and sale of a variety of CBD-based
products that can provide genuine help and effective relief to millions
of people suffering from a variety of qualifying conditions. Recent
reports and studies indicate the approval of the Farm Bill could create a
US$20 billion industry by 2022.
Increased Patient Access With a rapidly expanding
company-owned clinic network and significant expansion opportunity
assuming the successful acquisition of the Sun Valley
franchise model, Empower anticipates it will grow its total patient list
substantially in the years ahead. This is expected to provide greater
opportunity for treatment analysis using artificial intelligence (AI).
Market Leading Technology Empower utilizes a
market-leading patient electronic management and POS system that is
HIPAA compliant and provides insight to patient care. The Company
supports remote patients using its tele-medicine portal, enabling
patients who are unable to come to a location to benefit from a doctor
consultation.
The Debentures bear interest at the rate of 6.0% per annum and mature on May 3, 2020, being 12 months from the closing of the Offerings (the “Closing“). The Debentures are convertible, at the option of the Company or the holder, into units of the Company (each, a “Debenture Unit“) at a conversion price of $0.11 per Debenture Unit, with each Debenture Unit consisting of one common share in the capital of the Company (each, a “Share“) and one share purchase warrant (each, a “Warrant“), with each Warrant exercisable into one Share (each, a “Warrant Share“) at a price of $0.16
per Warrant Share for a period of two years following the Closing,
provided that the Company will have the right to accelerate the expiry
date of the Warrants in the event that the closing sale price of the
Shares on the Canadian Securities Exchange (the “CSE“) (or such other stock exchange as the Shares are then principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants.
Each Unit is comprised of one Share and one Warrant, with each
Warrant exercisable into one Warrant Share at an exercise price of $0.16
per Warrant Share for a period of two years following the Closing,
provided that the Company will have the right to accelerate the expiry
date of the Warrants in the event that the closing sale price of the
Shares on the CSE (or such other stock exchange as the Shares are then
principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants.
The Debentures and the Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the “Securities“),
are subject to restrictions on resale under applicable Canadian
securities laws for a period of four months and one day from the closing
of the Offerings. None of the Securities have been or will be
registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States
absent registration or an applicable exemption from the registration
requirements. This news release shall not constitute an offer to sell or
the solicitation of an offer to buy, nor shall there be any sale of the
securities, in any jurisdiction in which such offer, solicitation or
sale would require registration or otherwise be unlawful.
The Company also announces that Emily Davis has resigned
as a Director and member of the effective immediately. The Company
thanks Ms. Davis for her valuable contributions.
In addition, the Company announces that Dustin Klein has been appointed as a Director in conjunction with the previously announced closing of the Sun Valley acquisition.
ABOUT EMPOWER
Empower is a leading multi-state operator of a network of
physician-staffed clinics focused on helping patients improve and
protect their health through innovative physician recommended treatment
options. It is expected that Empower’s proprietary product line
“Sollievo” will offer patients a variety of delivery methods of doctor
recommended cannabidiol (CBD) based products in its clinics, online and
at major retailers. With over 165,000 patients, an expanding clinic
footprint, a focus on new technologies, including tele-medicine, and an
expanded product development strategy, Empower is undertaking new growth
initiatives to be positioned as a vertically integrated, diverse,
market-leading service provider for complex patient requirements in 2019
and beyond.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws. All
statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release. Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding: the proposed acquisition of Sun Valley;
the Company’s intention to open a hemp-based CBD extraction facility,
the expected benefits to the Company and its shareholders as a result of
the proposed acquisitions and partnerships; the terms of the proposed
acquisitions and partnerships; the expected location of the proposed CBD
extraction facility; the effectiveness of the extraction technology;
the size of the leased facility; the expected benefits for Empower’s
patient base and customers; access to Empower’s home delivery and
e-commerce platform; the benefits of CBD based products; the effect of
the approval of the Farm Bill; the growth of the Company’s patient list
and that the Company will be positioned to be a market-leading service
provider for complex patient requirements in 2019 and beyond. Such
statements are only projections, are based on assumptions known to
management at this time, and are subject to risks and uncertainties that
may cause actual results, performance or developments to differ
materially from those contained in the forward-looking statements,
including that: the proposed acquisitions and partnerships, including
the Sun Valley and Aibeida transactions, may not be
completed on the terms expected or at all; that the Company may not open
a hemp-based CBD extraction facility; that the hemp-based CBD
extraction facility may not be fully operation by Q2 2019 if at all;
that legislative changes may have an adverse effect on the Company’s
business and product development; that the Company may not be able to
obtain adequate financing to pursue its business plan; general business,
economic, competitive, political and social uncertainties; failure to
obtain any necessary approvals in connection with the proposed
acquisitions and partnerships; and other factors beyond the Company’s
control. No assurance can be given that any of the events anticipated by
the forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. Readers are cautioned not to
place undue reliance on the forward-looking statements in this release,
which are qualified in their entirety by these cautionary statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements in this release, whether as a result of new information,
future events or otherwise, except as expressly required by applicable
laws.
Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-6274Copyright CNW Group 2019
Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on Empower $CBDT.ca Announces Second Tranche Closing of Debenture and Unit Offerings and Announces Board of Director Changes $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 11:06 AM on Monday, May 6th, 2019
With a high grade graphite resource already in place, growing and situated in North America, Lomiko Metals (LMR:TSXV) believes it is on the verge of becoming a supplier to multiple gigafactories being built in North America to support the upcoming electric vehicle boom.
Grab a coffee, sit back and watch CEO Paul Gill beautifully explain where and why his high grade graphite will meet the demands of EV battery makers.
Online Education Provider Coursera Is Now Worth More Than $1 Billion
At Coursera, he’s put the company on a growth trajectory that includes expansion around the world.
After the U.S., Coursera’s greatest growth has come from India, China, Mexico and Brazil, in that order.
Coursera, one of the companies featured on Forbes’ 2018 list of Next Billion-Dollar Startups, is worth well over $1 billion, says its CEO, Jeff Maggioncalda. The seven-year-old online education provider, based in Mountain View, California, announced this morning that it had raised an additional $103 million in funding. “This gives us the resources to more aggressively push on our mission of greater access to quality education and greater opportunity for people who are being left behind in this economy,†he says.
Since our feature story on Coursera
last October, the number of registered learners on the site has climbed
from 36 million to 40 million. When we published, the company had been
valued at $800 million. Its revenue, which Forbes pegged at $140 million
in 2018, is fueled in part by partnerships with 1,800 enterprise
customers. They include Adobe, which paid Coursera an estimated $150,000
last year to provide machine-learning courses to Adobe employees.
Three months ago, Coursera signed a deal with the Abu Dhabi School of Government,
an entity set up to train 60,000 government employees in digital skills
like data science and artificial intelligence. Maggioncalda says that
partnership is Coursera’s most extensive to date.
Coursera also offers 14 online masters degrees,
in computer science, business and public health, from schools like the
University of Michigan and the University of Illinois at
Urbana-Champaign. And it just launched its first online bachelor of
science degree with the highly regarded University of London.
Coursera’s news comes at a time when critics like Kevin Carey,
director of education policy at the liberal-leaning New America
foundation, have raised concerns about the high cost of online degrees.
In a widely-read April article published in the Huffington Post,
headlined “The Creeping Capitalist Takeover of Higher Education,†he
wrote that online education should slash the price of a good degree. But
instead, many schools use online program managers, known as OPMs, to
produce and market their online courses. OPMs charge as much as 60% of
tuition for the service. Students who earn online degrees offered
through OPMs pay the same high tuition as they would if they studied on
campus. “What this means is that an innovation that should have been
used to address inequality is serving to fuel it,†he wrote. (Read
Forbes’ story on 2U, a leading OPM here.)
By contrast, Coursera does no course production and takes only 40% of
tuition. Its marketing costs are low, says Maggioncalda, because it
already reaches a huge number of learners. One example of a low-cost
Coursera degree: its online iMBA from the University of Illinois’ highly-ranked Gies College of Business, which costs $22,000. Out-of-state students pay $75,000 in tuition for an on-campus degree.
Though its partnerships with companies and its degree programs are
growing, he says the $49 fee (or subscription fee of $49-$99 per month)
learners pay to earn completion certificates for its wide selection of
courses that are open to the public still account for the largest share
of Coursera’s revenue.
Stanford computers science professors Daphne Koller and Andrew Ng
founded Coursera in 2012 as a platform to offer massive open online
courses, known as MOOCs. Their vision was to give students around the
world free access to college courses taught by professors from top
universities. At first, Coursera charged nothing to students, who earned
no academic credit. Princeton, Penn and Michigan signed on. Tremendous
hype followed, with thought leaders like the New York Times’
Thomas Friedman writing about Coursera and its fellow MOOC providers
Udacity and edEx, “Nothing has more potential to unlock a billion more
brains to solve the world’s problems.â€
The narrative soon switched to “the death of the MOOC,†after data
from two University of Pennsylvania studies showed that 80% of people
who registered for free MOOCs already had degrees and only half of them
bothered to look at a single lecture. A minuscule 4% completed their
courses.
In 2014 Coursera hired former Yale president Rick Levin and started
charging $30-$70 for course completion certificates. In 2017
Maggioncalda took over the top job. He had a track record running a
successful company started by Stanford professors. In 2010 he took
retirement planning website Financial Engines, founded by Nobel prize
winner William F. Sharpe and former SEC commissioner Joseph Grundfest,
public. By the time he left, its market cap was close to $2 billion and
his net worth was north of $50 million.
At Coursera, he’s put the company on a growth trajectory that
includes expansion around the world. After the U.S., Coursera’s greatest
growth has come from India, China, Mexico and Brazil, in that order.
The latest investment in Coursera was led by SEEK Group,
an Australian company with stakes in online employment and education
firms. SEEK was joined by previous Coursera investors Future Fund and
NEA. It brings Coursera’s total funding to $313 million.
Coursera is the second company on Forbes’ 2018 Next Billion-Dollar
Startup list to cross into unicorn territory this week. Read Amy
Feldman’s story about trucking industry technology provider KeepTruckin here.
Posted by AGORACOM-JC
at 10:03 AM on Monday, May 6th, 2019
SPONSOR: ThreeD Capital Inc. (IDK:CSE) Led by
legendary financier, Sheldon Inwentash, ThreeD is a Canadian-based
venture capital firm that only invests in best of breed small-cap
companies which are both defensible and mass scalable. More than just
lip service, Inwentash has financed many of Canada’s biggest small-cap
exits. Click Here For More Information.
——————-
PepsiCo Blockchain Trial Brings 28% Boost in Supply Chain Efficiency
Food and beverage giant PepsiCo has conducted a blockchain trial that brought a 28 percent boost in supply chain efficiency.
Dubbed “Project Proton,†the trial set out to examine if blockchain could address “industry challenges†in programmatic advertising.
Food and beverage giant PepsiCo has conducted a blockchain trial that brought a 28 percent boost in supply chain efficiency.
Dubbed “Project Proton,†the trial set out to examine if blockchain
could address “industry challenges†in programmatic advertising.
PepsiCo’s project partner and media agency Mindshare announced the
news Monday, saying that it assisted in the trial, which carried out
a programmatic end-to-end supply chain reconciliation using Zilliqa’s
blockchain platform. The effort compared a control budget with one for
the test to gauge the effectiveness of the technology.
Zilliqa’s smart contracts were further used to automate the programmatic supply chain, Mindshare said, explaining:
“These smart contracts reconcile impressions that are delivered from
multiple data sources with payments facilitated using an internal Native
Alliance Token (NAT) all in near real time, resulting in major
efficiency gains and complete transparency for the brand owners.â€
The results indicated efficiency increases “in terms of costs for
viewable impressions, in running the campaign through smart contracts,
versus one without,†according to Mindshare.
Other partners in the project included online advertising company
Rubicon, programmatic marketing technology firm MediaMath and media firm
Integral Ad Science.
The trial was conducted in March in the Asia Pacific region. The
partners now plan to run a second phase with the addition of payments to
publishers and more performance metrics.
Farida Shakhshir, PepsiCo’s director of consumer engagement for the Asia, Middle East and North Africa regions, said:
“The results are encouraging, and we plan to run a few more campaigns
under different conditions to verify more hypotheses and measure
overall impact.â€
Posted by AGORACOM
at 8:20 AM on Monday, May 6th, 2019
Shipped an additional 100 Kilograms of Wollastonite from its St-Onge deposit for use at BC Bud Depot ACMPR-licenced Research and Development facilities
The wollastonite will be used as a natural soil additive to enhance overall cannabis plant health and improve cultivation and production
Adding wollastonite at an admixture rate of 10-15% to the growth medium will result in significant improvements in root mass, powdery mildew control and pest elimination
VANCOUVER, BC / ACCESSWIRE / May 6, 2019 / VERTICAL
EXPLORATION INC. (TSX-V: VERT) (“Vertical” or the “Company”) is pleased
to announce that it has shipped an additional 100 Kilograms of
wollastonite from its St-Onge deposit for use at BC Bud Depot’s (BCBD)
ACMPR-licenced Research and Development facilities in Vancouver, BC. The
wollastonite will be used as a natural soil additive to enhance overall
cannabis plant health and improve cultivation and production at BCBD’s
facilities.
Peter P. Swistak, president and chief executive
officer of Vertical Exploration, commented: “We are very happy to
provide this additional shipment of wollastonite to BCBD for use at
their Vancouver cannabis facilities, as it further validates the success
of the Phase Three cannabis research trials that took place earlier
this year at BCBD’s facilities which were announced by the Company on
February 5th, 2019. This shipment is also further confirmation of
Vertical’s efforts to aggressively move forward with additional test
marketing of our high-quality St. Onge wollastonite with a range of
cannabis industry companies and producers.”
“We are thrilled to be
able to receive an additional shipment of Vertical’s wollastonite to
support cannabis cultivation at our ACMPR-licenced Research and
Development facilities,” stated Matthew Harvey, CEO of BCBD. “After
being part of the very encouraging Phase Three cannabis trials, I am
convinced that adding wollastonite at an admixture rate of 10-15% to the
growth medium will result in significant improvements in root mass,
powdery mildew control and pest elimination. I firmly believe that
wollastonite, with all of its highly beneficial plant health properties,
will be increasingly seen by the cannabis industry as the natural
mineral supplement answer because it couples crop protection with
product improvement which ultimately means a more natural and healthier
product for consumers.”
Vertical anticipates providing further updates on its cannabis testing and marketing efforts in the coming months.
ABOUT VERTICAL EXPLORATION
Vertical
Exploration’s mission is to identify, acquire, and advance high
potential mining prospects located in North America for the benefit of
its stakeholders. The Company’s flagship St-Onge Wollastonite property
is located in the Lac-Saint-Jean area in the Province of Quebec.
Neither
the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 3:03 PM on Friday, May 3rd, 2019
Announced the receipt of an interim progress report from PyroGenesis (TSX-V: PYR) highlighting results of GEN2’s material compatibility tests done under actual operating condition
PUREVAP™ is a harsh process for materials because of the very high temperatures sustained during operations and the presence of liquid metal
To validate material selection, experimental tests, focused on the two sections of the reactor susceptible to intense wear and tear were conducted using the GEN2 PUREVAP™
For the material chosen for the GEN3, the test were deemed a success since inspection after the test showed no silicon melt attack to the material and no dissolution of the walls by liquid metal
MONTREAL, May 03, 2019 — HPQ Silicon Resources Inc. (HPQ) (TSX-V:“HPQâ€)(FRANKFURT:UGE)(OTC PINK:URAGF) is pleased to announce the receipt of an interim progress report from PyroGenesis Canada Inc (“PyroGenesisâ€) (TSX-V: PYR) highlighting results of GEN2’s material compatibility tests done under actual operating condition.
The PUREVAP™ is a harsh process for materials because of the very high temperatures sustained during operations and the presence of liquid metal. This is why parts of the system which are in proximity of the high temperature regions and liquid metal need to be lined with material that is compatible with the harsh environment. To validate material selection, experimental tests, focused on the two sections of the reactor susceptible to intense wear and tear were conducted using the GEN2 PUREVAP™.
GEN2 AN INVALUABLE ASSET THAT ALLOWS TESTING UNDER ACTUAL OPERATIONAL CONDITIONS
The GEN2 tests conducted to study the compatibility of the material
chosen were done under actual operational conditions, whereby once a
pool of silicon metal was created inside the reactor, the tap hole was
opened to drain metal out of the reactor and the reactor was inspected
for damages or un-expected wear and tear.
For the material chosen for the GEN3, the test were deemed a success
since inspection after the test showed no silicon melt attack to the
material and no dissolution of the walls by liquid metal.
“This is another demonstration of where the meticulous approach to R&D and proven track record of taking projects from proof of concept to commercialization of PyroGenesis provides great value to the HPQ PUREVAP™ project†said Bernard J. Tourillon President and CEO of HPQ Silicon Resources. “We are none only reducing the overall risk of the project, we have also ticked off another box in our goal to create both a low cost and green metallurgical approach to producing solar grade silicon metal“.
Pierre Carabin, Eng., M. Eng., Chief Technology Officer and Chief
Strategist of PyroGenesis has reviewed and approved the technical
content of this press release.
In accordance with the agreement between HPQ-Silicon and Agoracom,
entered into on July 3, 2014, extended by both parties for additional
periods ending July 15, 2018 and July 15, 2019 under the same terms and
conditions, HPQ-Silicon board has approved the issuance of 188,333
common shares at a deemed price of 7,5 cents per share to pay $14,125
for services rendered during the period from July 16, 2018 ending
October 15, 2018 and HPQ board has also approved the issuance of 235,416
common shares at a deemed price of 6 cents per share to pay $14,125 for
services rendered during the period from October 16, 2018 ending
January 15, 2019. Each share issued pursuant to the debt settlement
will have a mandatory four (4) month and one (1) day holding period from
the date of closing.
Furthermore, the Directors of the Corporation have agreed to settle a
$75,000.00 debt for services rendered by a service provider to the
Corporation by issuing 750,000 units (“Unit”) at a price of $0.10 per
Unit. Each Unit is comprised of 1 common share and 1 common share
purchase warrant of the Corporation. Each Warrant will entitle the
holder thereof to purchase one common share of the capital stock of the
Company at an exercise price of $ 0.15 per share for a period of 24
months. Each share issued pursuant to the debt settlement will have a
mandatory four (4) month and one (1) day holding period from the date of
closing. This settlement is subject to the approval of the TSX Venture
Exchange.
This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
About HPQ Silicon
HPQ Silicon Resources Inc. is a TSX-V listed (Symbol HPQ) resource company focuses on becoming a vertically integrated producer of High Purity Silicon Metal (4N+) and a metallurgical producer of Solar Grade Silicon Metal (“SoG-Siâ€) used in the manufacturing of multi and monocrystalline solar cells of the P and N types, required for production of high performance photovoltaic solar systems.
HPQ’s goal is to develop, in collaboration with industry leaders,
PyroGenesis (TSX-V: PYR) and Apollon Solar, experts in their fields of
interest, the innovative PUREVAPTM “Quartz Reduction Reactors (QRR)â€, a
new Carbothermic process (patent pending), which will permit the
transformation and purification of quartz (SiO2) into high purity
silicon metal (4N+ Si) in one step and therefore reduce significantly
the CAPEX and OPEX costs associated with a metallurgical transformation
of quartz (SiO2) into SoG Si. The pilot plant equipment that will
validate the commercial potential of the process is on schedule to start
mid-2019
Disclaimers:
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward-looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Company’s current expectation and assumptions, and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Company with respect to future events and are subject to certain risks
and uncertainties and other risks detailed from time-to-time in the
Company’s on-going filings with the securities regulatory authorities,
which filings can be found at www.sedar.com. Actual results, events, and
performance may differ materially. Readers are cautioned not to place
undue reliance on these forward-looking statements. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements either as a result of new information, future
events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this
release.
For further information contact Bernard J. Tourillon, Chairman, President and CEO Tel: (514) 907-1011 Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239 www.HPQSilicon.com
